97 related articles for article (PubMed ID: 24446743)
21. Prevalence of human papillomavirus, Epstein-Barr virus, and cytomegalovirus in fine needle aspirates from lung carcinoma: A case-control study with review of literature.
Gupta P; Haldar D; Naru J; Dey P; Aggarwal AN; Minz RW; Aggarwal R
Diagn Cytopathol; 2016 Dec; 44(12):987-993. PubMed ID: 27774746
[TBL] [Abstract][Full Text] [Related]
22. EGFR mutations and human papillomavirus in lung cancer.
Kato T; Koriyama C; Khan N; Samukawa T; Yanagi M; Hamada T; Yokomakura N; Otsuka T; Inoue H; Sato M; Natsugoe S; Akiba S
Lung Cancer; 2012 Nov; 78(2):144-7. PubMed ID: 22975156
[TBL] [Abstract][Full Text] [Related]
23. Metachronous squamous cell carcinomas evolving from independent oropharyngeal and pulmonary squamous papillomas: association with human papillomavirus 11 and lack of aberrant p53, Rb, and p16 protein expression.
Xu H; Lu DW; El-Mofty SK; Wang HL
Hum Pathol; 2004 Nov; 35(11):1419-22. PubMed ID: 15668901
[TBL] [Abstract][Full Text] [Related]
24. Esophageal squamous cell cancer in patients with head and neck cancer: Prevalence of human papillomavirus DNA sequences.
de Villiers EM; Gunst K; Stein H; Scherübl H
Int J Cancer; 2004 Mar; 109(2):253-8. PubMed ID: 14750177
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma.
Pinto AP; Schlecht NF; Pintos J; Kaiano J; Franco EL; Crum CP; Villa LL
Gynecol Oncol; 2004 Mar; 92(3):856-65. PubMed ID: 14984953
[TBL] [Abstract][Full Text] [Related]
26. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
27. Assessment of human papilloma virus infection in adult laryngeal papilloma using a screening test.
Makiyama K; Hirai R; Matsuzaki H; Ikeda M
J Voice; 2013 Mar; 27(2):230-5. PubMed ID: 23273988
[TBL] [Abstract][Full Text] [Related]
28. [Detection of human papillomavirus DNA in squamous cell carcinomas of the lung by multiple polymerase chain reaction].
Xing LQ; Liu HR; Si JY
Zhonghua Jie He He Hu Xi Za Zhi; 1993 Oct; 16(5):275-7, 319. PubMed ID: 7923430
[TBL] [Abstract][Full Text] [Related]
29. Detection of EML4-ALK fusion genes in non-small cell lung cancer patients with clinical features associated with EGFR mutations.
Shaozhang Z; Xiaomei L; Aiping Z; Jianbo H; Xiangqun S; Qitao Y
Genes Chromosomes Cancer; 2012 Oct; 51(10):925-32. PubMed ID: 22736493
[TBL] [Abstract][Full Text] [Related]
30. Squamous cell carcinoma arising in recurrent respiratory papillomatosis with pulmonary involvement: emerging common pattern of clinical features and human papillomavirus serotype association.
Cook JR; Hill DA; Humphrey PA; Pfeifer JD; El-Mofty SK
Mod Pathol; 2000 Aug; 13(8):914-8. PubMed ID: 10955460
[TBL] [Abstract][Full Text] [Related]
31. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan.
Chiou HL; Wu MF; Liaw YC; Cheng YW; Wong RH; Chen CY; Lee H
Cancer; 2003 Mar; 97(6):1558-63. PubMed ID: 12627521
[TBL] [Abstract][Full Text] [Related]
32. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
[TBL] [Abstract][Full Text] [Related]
33. Human papillomavirus detection in cervical carcinoma tissues and paraaortic lymph nodes by the polymerase chain reaction.
Park JS; Chee YH; Namkoong SE; Han SK; Kim TE; Lee HY; Kim SJ
Gynecol Oncol; 1994 Jun; 53(3):344-51. PubMed ID: 8206408
[TBL] [Abstract][Full Text] [Related]
34. Time trends in the prevalence of HPV in oropharyngeal squamous cell carcinomas in northern Spain (1990-2009).
Rodrigo JP; Heideman DA; García-Pedrero JM; Fresno MF; Brakenhoff RH; Díaz Molina JP; Snijders PJ; Hermsen MA
Int J Cancer; 2014 Jan; 134(2):487-92. PubMed ID: 23824638
[TBL] [Abstract][Full Text] [Related]
35. Human papillomavirus DNA and p16 gene in squamous cell lung carcinoma.
Gatta LB; Balzarini P; Tironi A; Berenzi A; Benetti A; Angiero F; Grigolato P; Dessy E
Anticancer Res; 2012 Aug; 32(8):3085-9. PubMed ID: 22843877
[TBL] [Abstract][Full Text] [Related]
36. High-risk human papillomavirus (HPV) is not associated with p53 and bcl-2 expression in oral squamous cell carcinomas.
Oliveira MC; Soares RC; Pinto LP; Souza LB; Medeiros SR; Costa Ade L
Auris Nasus Larynx; 2009 Aug; 36(4):450-6. PubMed ID: 19124208
[TBL] [Abstract][Full Text] [Related]
37. [A study of human papillary virus infection by in situ hybridization and histopathology in squamous cell carcinoma of the lung].
Liu HR; Xing LQ; Si JY
Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):299-301. PubMed ID: 7874766
[TBL] [Abstract][Full Text] [Related]
38. [Study on the association between squamous cell carcinoma of larynx and HPV subgene by PCR].
Wang L; Zhang T; Zhang F
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1999 Apr; 34(2):106-7. PubMed ID: 12764861
[TBL] [Abstract][Full Text] [Related]
39. Phosphoinositide-3-kinase catalytic alpha and KRAS mutations are important predictors of resistance to therapy with epidermal growth factor receptor tyrosine kinase inhibitors in patients with advanced non-small cell lung cancer.
Ludovini V; Bianconi F; Pistola L; Chiari R; Minotti V; Colella R; Giuffrida D; Tofanetti FR; Siggillino A; Flacco A; Baldelli E; Iacono D; Mameli MG; Cavaliere A; Crinò L
J Thorac Oncol; 2011 Apr; 6(4):707-15. PubMed ID: 21258250
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors.
Iftner A; Klug SJ; Garbe C; Blum A; Stancu A; Wilczynski SP; Iftner T
Cancer Res; 2003 Nov; 63(21):7515-9. PubMed ID: 14612553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
